Tremblant Capital Group’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-93,510
Closed -$19.2M 46
2017
Q3
$19.2M Sell
93,510
-1,778
-2% -$413K 0.85% 30
2017
Q2
$23.2M Buy
95,288
+6,960
+8% +$1.64M 1.65% 22
2017
Q1
$21.1M Buy
88,328
+9,151
+12% +$2.13M 1.47% 23
2016
Q4
$16.6M Buy
79,177
+11,797
+18% +$2.44M 1.06% 32
2016
Q3
$15.5M Buy
67,380
+13,117
+24% +$3.21M 0.87% 35
2016
Q2
$12.5M Sell
54,263
-1,990
-4% -$459K 0.73% 39
2016
Q1
$15.1M Sell
56,253
-1,026
-2% -$294K 0.89% 37
2015
Q4
$17.9M Buy
+57,279
New +$17.1M 1.13% 34

Other funds holding AGN

Tremblant Capital Group's AGN Position: Q4 2017 in Review

Tremblant Capital Group sold out of Allergan plc (AGN) in Q4 2017, closing a stake of 93,510 shares — an estimated $19.2M sold.

Tremblant Capital Group first reported a position in AGN in Q4 2015 and held it in 8 quarters. The position peaked at $23.2M in Q2 2017. 1,048 funds tracked by Wall St. Rank hold AGN as of Q4 2017.

  • Tremblant Capital Group reported no remaining Allergan plc position as of Q4 2017 after selling out during the quarter.
  • Tremblant Capital Group sold 93,510 Allergan plc shares in Q4 2017, an estimated $19.2M.
  • Tremblant Capital Group first reported a position in Allergan plc in Q4 2015 and held it in 8 quarters.
  • Tremblant Capital Group's Allergan plc position peaked at $23.2M in Q2 2017.
  • 1,048 funds tracked by Wall St. Rank held Allergan plc as of Q4 2017.

Based on Tremblant Capital Group's 13F filing for Q4 2017, filed 14 Feb 2018.